Characterization of Bridging Integrator 1 (BIN1) as a Potential Tumor Suppressor and Prognostic Marker in Hepatocellular Carcinoma
Open Access
- 23 January 2012
- journal article
- Published by Springer Science and Business Media LLC in Molecular Medicine
- Vol. 18 (1), 507-518
- https://doi.org/10.2119/molmed.2011.00319
Abstract
It has been shown that bridging integrator 1 (BIN1) can interact with c-myelocytomatosis (c-Myc) oncoprotein in cancer. However, the role of BIN1 in hepatocellular carcinoma (HCC) is not clear. In the present study, we investigated the expression and prognostic role of BIN1 in primary HCC and evaluated the function of BIN1 in hepatocarcinogenesis. Using real-time polymerase chain reaction and Western blot analysis, we found significantly decreased expression of BIN1 in primary HCC tumor tissues (n = 42) compared with adjacent normal tissues and in HCC cell lines. Immunohistochemistry analysis also found decreased BIN1 expression in HCC tumor tissues (n = 117). In clinicopathological analysis, loss of BIN1 expression correlated significantly (P < 0.05) with differentiation scores and tumor size. Importantly, decreased expression of BIN1 in tumors was found to be closely associated with a poor prognosis, and we conclude that BIN1 was an independent prognostic factor in a multivariate analysis. In mechanistic studies, restoring BIN1 expression in BIN1-null HCC cells significantly inhibited cell proliferation and colony formation and induced apoptosis of HCC cells. Furthermore, we found that BIN1 overexpression could significantly suppress the motility and invasion of HCC cells in vitro. Our results indicate that BIN1 may function as a potential tumor suppressor and serve as a novel prognostic marker in HCC patients. The BIN1 molecule might play an important role in tumor growth, cell motility and invasion. Modulation of BIN1 expression may lead to clinical applications of this critical molecule in the control of hepatocellular carcinoma as well as in early and effective diagnosis of this aggressive tumor.Keywords
This publication has 24 references indexed in Scilit:
- The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damageCell Death & Differentiation, 2009
- Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cellsBlood, 2009
- Bin1 is linked to metastatic potential and chemosensitivity in neuroblastomaPediatric Blood & Cancer, 2009
- Bin1 Ablation Increases Susceptibility to Cancer during Aging, Particularly Lung CancerCancer Research, 2007
- Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survivalCancer Biology & Therapy, 2007
- Methylation of the BIN1 gene promoter CpG island associated with breast and prostate cancerJournal of Carcinogenesis, 2007
- Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1Oncogene, 2003
- The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death programOncogene, 2000
- Induction of apoptosis and differentiation in neuroblastoma and astrocytoma cells by the overexpression of Bin1, a novel myc interacting proteinJournal of Cellular Biochemistry, 1999
- Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanismsOncogene, 1999